Skip to main content

Tm Biosciences Receives US, Canadian Standards Certifications for Genetic Tests

NEW YORK, Nov. 3 (GenomeWeb News) - Tm Bioscience of Toronto has received a certification that its processes meet standards for both US and Canadian medical device standards, the company said today.


The company's quality management system has been certified to both the ISO 13485:1996 standard and the requirements of the Canadian Medical Devices Conformity Assessment System, the company said. The certificate covers processes for development, manufacture, and distribution of genetic tests for mutations in the areas of hematology, cystic fibrosis, toxicology, and other areas, as well as analyte specific reagents, in vitro diagnostic medical devices, and software used to test for genetic mutations, according to Tm.


Tm launched its P450 2D6 test in June.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.